60 Series 16 Part 1 Exam Concepts You Need to Know Before Test Day

Rule 2241(a)(11) defines a research report as a written or electronic communication that includes analysis, valuation, investment advice, or opinions on equity securities or their issuers, and that also contains individualized investment advice and/or a recommendation. The SA makes the classification call by reading the substance, not the label. A note titled market commentary that ends with a recommendation to accumulate the shares is a research report; a formal document on broad market conditions may not be. Everything downstream, including SA approval, disclosures, quiet periods, and analyst trading restrictions, attaches only if this definition is met, so the classification decision drives the entire compliance workflow.

Memory hook:Substance over title: a recommendation hidden in commentary still makes it a research report.

Rule 2241(a)(11) carves out several communications from the research report definition: discussions of broad-based indexes; commentary on economic, political, or market conditions; technical analysis of the demand for or supply of a sector, index, or industry based on trading volume and price; statistical summaries of multiple companies' financial data, including listings of current ratings; and notices of ratings or price target changes that meet specified conditions. Research on securities other than equity securities is also outside the definition. These items can still be approved by an SA with technical expertise in the product area, but they do not trigger the full 2241 apparatus of disclosures, quiet periods, and analyst trading restrictions.

Memory hook:Indexes, economics, technicals, statistical summaries are excluded; add a recommendation and inclusion returns.

Rule 2241 requires every research report to be approved by a supervisory analyst before publication. That approval is separate from and in addition to the registered principal approval required by Rule 2210(b)(1) for retail communications. Neither substitutes for the other: the SA reviews substance, including reasonable basis, valuation support, and disclosure completeness, while the principal confirms the communication meets Rule 2210 content standards and firm procedures. A report signed off by a principal but never reviewed by an SA violates 2241; the reverse violates 2210. The SA must also hold the technical expertise, and any product-specific registrations, for the product the report covers.

Memory hook:Two signatures, two rules: SA for substance under 2241, principal for 2210.

Rule 2210 sorts communications into three tiers. Retail communications go to more than 25 retail investors within 30 calendar days and require pre-approval by a registered principal, with certain categories also filed with FINRA. Institutional communications are distributed to institutional investors as defined in the rule; they need no principal pre-approval, but the firm must have a reasonable basis for believing the recipients qualify. Correspondence goes to 25 or fewer retail investors within 30 calendar days and is supervised through review under Rule 3110 rather than mandatory pre-approval. A research report sent to an institution is still a research report under 2241; the 2210 tier relaxes the principal step, not the research rules.

Memory hook:More than 25 retail in 30 days equals retail communication; institutional needs reasonable basis, not pre-approval.

Standard SA and principal review does not end the inquiry in every situation. When the report concerns an issuer with which the firm has a current investment banking relationship or pending investment banking services, Rule 2241 requires review by legal or compliance personnel before publication to guard against conflicts leaking into the analysis. Complex or specialized products, such as structured notes, options, or mortgage-backed strategies, call for a product specialist who understands the instrument, and the SA may need additional product-specific registrations to approve it. The decision rule: the moment a deal, a conflict, or product complexity enters the picture, route the report beyond the SA before it goes out the door.

Memory hook:Deal on the table or complex product: add legal, compliance, or specialist eyes.

Rule 2241 governs research on equity securities. Rule 2242 governs research on debt securities, with its own definitions, conflict-of-interest provisions, and disclosure requirements, and it deliberately excludes municipal securities from its definition of debt security. Municipal research instead falls under MSRB rules, which impose their own supervisory and disclosure framework on municipal securities dealers. The SA has to sort the report into the right bucket before approving anything, because the required disclosures, approval mechanics, and analyst trading restrictions differ across the three regimes. A report on a corporate bond is not reviewed under 2241, and an equity report does not pick up 2242 obligations.

Memory hook:Equity 2241, debt 2242, municipal goes to the MSRB.

NYSE Rule 344 sets the qualification and approval framework for research personnel. Research analysts must meet qualification standards, established through the Research Analyst exams, before producing research, and firms must designate supervisory analysts, qualified through the Series 16, to approve research reports. Rule 344 works alongside FINRA Rule 2241: the SA who signs off on a report must be registered under the NYSE framework, and the analyst who wrote it must be registered as a research analyst. The SA's review is substantive, not clerical. The rule contemplates a qualified person exercising judgment about the report's content, not merely checking that a form was completed.

Memory hook:Rule 344: right exams for the right chairs, qualified to write, qualified to approve.

A restricted list is the firm's internal list of issuers about which it holds material nonpublic information, typically because of a pending underwriting, advisory, or lending engagement. While an issuer is on the list, the firm cannot publish research on it, trade in its securities for its own or customer accounts, or recommend it. Before approving any report, the SA must run the pre-publication check: confirm the issuer is not restricted. Publishing on a restricted issuer risks selective disclosure of material nonpublic information and undermines the information barriers the list exists to protect. The list itself is confidential; its existence and contents are not shared with the sales force or analysts.

Memory hook:Restricted list equals total silence: no research, no trades, no recommendations.

Watch lists and restricted lists are different tiers of the same control system. A watch-listed issuer is one where the firm may become involved in a transaction or where heightened concern exists. Research can continue, but with disclosure of any potential conflict and closer supervisory attention; trading may be limited for certain personnel. A restricted-listed issuer, by contrast, is off limits entirely: no research, no trading, no recommendations, because the firm actually holds material nonpublic information. The SA's job is to know which list the issuer sits on, because the permissibility answer flips completely. Watch list means proceed with caution and disclosure; restricted list means stop.

Memory hook:Watch means caution with disclosure; restricted means hands off completely.

Rule 2241 imposes quiet periods on underwriters of securities offerings. A firm that acted as manager or co-manager of an initial public offering may not publish research on the subject company for 10 calendar days after the date of the IPO. For a secondary offering, the quiet period runs 3 calendar days after the date on which the transaction was consummated, not the registration statement's effective date. The restriction applies to the manager or co-manager; a non-underwriting firm is free to publish. The SA checks the firm's role in the deal and counts the days before approving anything on the subject issuer. These blackout windows prevent an underwriter from using research to support the aftermarket price of a deal it just brought.

Memory hook:IPO ten, secondary three from consummation, and only for the deal's managers.

The JOBS Act created an exception to the quiet period framework for emerging growth companies. For an EGC's IPO, the Rule 2241 quiet periods do not apply: underwriters may publish research on the EGC before the offering and after it without waiting out the 10-day window, and such research is not deemed an offer to sell the securities. The SA's task is to confirm the issuer genuinely qualifies as an EGC under the JOBS Act definition and that all otherwise-required Rule 2241 disclosures and content standards still accompany the research. If the issuer is not an EGC, the standard quiet periods apply in full.

Memory hook:EGC: quiet period off; ordinary rules still on.

Regulation M Rule 101 prohibits a distribution participant from bidding for or purchasing the offered security during the restricted period before an offering. For actively traded securities, the restricted period begins one business day before pricing; for other securities, it is keyed to one business day before pricing and the day the distribution participant agrees to participate in the offering. Rule 101(b)(1) supplies a research exception: a distribution participant may publish or supply a research report during the restricted period if the report is published in the ordinary course, prepared by a research analyst, contains no new or nonpublic information about the issuer or the offering, is furnished to legal or compliance in advance, and the firm does not trade contrary to the recommendation.

Memory hook:Reg M 101: no buying the offered security; research survives only if ordinary-course and pre-cleared.

Rule 101(c)(1) excepts certain actively traded securities from Rule 101's purchase restriction altogether: an equity security with average daily trading volume of at least one million dollars and public float of at least 150 million dollars qualifies, and debt securities must also be investment grade. For excepted securities, distribution participants face no Rule 101 purchase prohibition, so the research question largely dissolves. For securities that do not qualify, the Rule 101(b)(1) research exception is the only path, and its conditions are strict: bona fide report, analyst-authored, no new nonpublic information, advance legal or compliance review, and no trading contrary to the recommendation. The SA first tests excepted status, then falls back to the exception.

Memory hook:One million traded, 150 million float: excepted, and Rule 101 fades away.

Rules 137, 138, and 139 are Securities Act safe harbors that keep research reports from being deemed prospectuses under Section 5. Rule 137 protects research published by brokers or dealers not participating in the issuer's registered distribution, the broadest protection. Rule 138 lets a distribution participant publish research on securities other than those it is distributing. Rule 139 is the narrowest: it lets a participating underwriter publish research on the very securities it is distributing, but only if the report is bona fide, prepared by a research analyst, and no more favorable than recent practice. Match the firm's role to the correct rule; the wrong safe harbor offers no protection at all.

Memory hook:137 outside the deal, 138 other securities, 139 the deal itself.

FINRA Rule 5280 addresses the information edge a member gets when it receives advance notice of another member's research report likely to have a material market impact. The member cannot trade the subject security for its own account, or for accounts of persons aware of the upcoming report, before publication. The rule reaches proprietary trading desks and the personal accounts of employees with knowledge of the report. A firm can avoid problems by maintaining and enforcing policies reasonably designed to prevent misuse of the information. Exceptions exist for bona fide market making and unsolicited customer orders. The SA should ensure the firm's information barriers and watch procedures capture incoming third-party reports.

Memory hook:Someone else's report in hand means your trading hands stay tied.

Rule 2241 restricts analyst personal trading in subject securities. The core prohibition: an analyst cannot trade contrary to a current recommendation, meaning no selling shares of a company the analyst rates buy or equivalent, and no buying shares of a company rated sell or underperform. Layered on top are blackout periods: no trading in the subject security during the 30 days before and the 5 days after publication of a research report on it. Trades generally require preclearance through legal or compliance, and analysts cannot trade while possessing material nonpublic information about the issuer. The SA reviewing a report should also be checking the analyst's trading record against these windows and the current rating.

Memory hook:Never against your rating, never within 30 before or 5 after.

Rule 2210(d) requires that recommendations have a reasonable basis, and Rule 2241 obligates the analyst to have a reasonable basis for each rating and price target. The SA's review asks whether the data actually supports the conclusion: are the valuation methods appropriate for the company, consistently applied, and reconciled with the financial statements; do the estimates and assumptions hold up; is the rating aligned with the price target and the report's own analysis? A buy rating sitting on top of a target below the current market price fails on its face. Reasonable basis does not require the SA to agree with the call; it requires a defensible, internally consistent path from evidence to conclusion.

Memory hook:Reasonable basis means the evidence, method, target, and rating all point the same way.

Rule 2241 requires that a price target in a research report be supported, and the support must be visible to the reader. The report must state the basis for the target, meaning the valuation methodology such as discounted cash flow, comparable multiples, or a combination, and the time horizon within which the target is expected to be attained, so readers can judge attainability. The report should also make clear that the target may not be achieved. The SA verifies three things: the methodology is described and sensible, the horizon is stated, and the target is consistent with the rating and the report's analysis. A bare number with no stated basis does not pass.

Memory hook:A price target needs its basis, its method, and its deadline in print.

Research reports must include a discussion of the risks of investing in the security, and FINRA's guidance is explicit that boilerplate does not satisfy the requirement. Generic language about market volatility pasted identically into every report is inadequate; the risk discussion must address the specific risks of the issuer and the investment thesis, whether competitive pressures, regulatory exposure, concentration, leverage, or execution risk, whatever actually threatens the case for the stock. The requirement flows from the fair and balanced presentation standard in Rule 2210(d): a report that presents only the upside is unbalanced and misleading. The SA should ask whether the named risks are the ones that could genuinely break the thesis.

Memory hook:Risks must name what actually breaks the thesis, not recycle boilerplate.

Rule 2210(d) requires communications to be fair, balanced, and not misleading, which means the report must distinguish factual statements, such as verifiable data like earnings, market cap, and trading volume, from the analyst's opinions and estimates. Projections and forecasts must be labeled as such, with the assumptions and basis disclosed, so the reader knows what is known versus what is guessed. Promissory and exaggerated language is barred: a claim that a stock will double or that returns are guaranteed has no place in research. NYSE Rule 435(5) reinforces this by prohibiting the circulation of rumors. The SA reads for these lines: every factual claim should be sourced, every projection labeled, every opinion recognizable as opinion.

Memory hook:Source the facts, label the projections, keep will and guarantee out.

Rule 2210(d) requires every communication to be fair, balanced, not misleading, and based on a reasonable basis, and it specifically bans exaggerated, unwarranted, or promissory statements. Language that promises a result — guaranteed returns, riskless arbitrage, a sure double — fails no matter how confident the analyst feels. Superlatives like best in class are acceptable only when literally true and supportable with evidence. Opinion must be labeled as opinion, and certainty claims must match what the analysis actually shows. The Supervisory Analyst's job is to strike promises, soften absolutes, and make sure any risk discussion parallels the strength of the benefit claims.

Memory hook:If it promises a result, it fails; if it is provable, it passes.

Rule 2210(d) prohibits omitting facts that would make the included statements misleading, and it requires balanced treatment of risk and benefit. The trap: a report can contain only true sentences and still violate the rule. Touting a company's growth pipeline while never mentioning pending litigation, dilution, or intensifying competition leaves the reader with a false impression even though nothing said was false. The decision rule for a Supervisory Analyst is to ask what a reasonable reader needs to weigh the claim; if a material negative is missing, the communication is misleading. Fair presentation is judged on the whole picture, not on sentence-by-sentence accuracy.

Memory hook:True statements with missing risks still paint a false picture.

Rule 2210 permits citing past performance, but only with context. When a report touts the results of prior recommendations, it must include the performance of all stocks in the related universe, not just the winners; indicate the general market conditions during the period covered; and state that past performance does not guarantee future results. Cherry-picking the analyst's best calls is the violation. The exam's own sample item confirms the pattern: twelve months of whole-universe performance, market conditions, and the disclaimer are all required, while a multi-year price history for the single highlighted stock is not. Decision rule: full universe, market context, disclaimer — every time performance appears.

Memory hook:Whole universe, market backdrop, disclaimer — three items whenever track records appear.

The Supervisory Analyst's approval authority expressly covers notices of ratings or price target changes, but only when conditions are met. The notice must reference the analyst's most recent research report on the subject company, state the change and its effective date, and include the required disclosures or direct readers to where they appear in the referenced report. A notice that adds new analysis, fresh estimates, or a new investment thesis becomes a research report requiring full review. The mechanism is simple: the notice piggybacks on an already-approved report. Decision rule: a change plus a pointer passes; a change plus new content does not.

Memory hook:Announce and point back: safe. Add new analysis: it is a report.

Technical analysis concerning the demand and supply for a sector, index, or industry based on trading volume and price sits squarely within the Supervisory Analyst's approval authority. It is not company-specific fundamental research, but it still must satisfy Rule 2210: reasonable basis, opinion distinguished from fact, and no exaggerated claims. A piece asserting that an uptrend will continue, with nothing behind it, fails; one explaining that rising volume is confirming a breakout, framed as interpretation of observed data, passes. Decision rule: conclusions must be tied to the observed volume and price data and presented as analysis, not as a guaranteed forecast.

Memory hook:Volume and price for a sector or index — approvable; guarantees still fail.

NYSE Rule 435(5) bars a member from originating or circulating rumors about securities, especially rumors calculated to induce purchases or sales. The anti-fraud overlay — FINRA Rules 2010 and 2020 and Exchange Act Rule 10b-5 — means passing along a rumor the member has not verified can amount to fraud, not harmless market chatter. For the Supervisory Analyst, the practical task is keeping rumor out of research: fact, opinion, and rumor must be distinguished, and unverified takeover or merger talk either gets labeled as unverified rumor or left out entirely. Decision rule: never originate, never repeat without verification, always label.

Memory hook:Originate it or repeat it — either way, the rumor is yours.

Rule 2241 requires research reports to disclose ownership interests in the subject company. The report must state whether the research analyst or a member of the analyst's household beneficially owns securities of the subject company, with ownership of one percent or more of any class triggering disclosure, and the firm's own beneficial ownership of one percent or more must be disclosed as well. Household reach means a spouse's or dependent's shares count as the analyst's for this purpose. The mechanism is transparency: readers cannot judge an analyst's independence without knowing who holds what. SA decision rule: sweep analyst accounts, household accounts, and firm inventory before release.

Memory hook:Analyst, household, firm — anyone holding one percent gets disclosed.

Rule 2241 requires research reports to disclose the firm's material relationships with the subject company so readers can weigh independence. The core set: whether the firm received investment banking compensation from the company within the preceding twelve months; whether the firm makes a market in the subject security; whether the firm received other compensation from the company, such as advisory fees; and whether the firm beneficially owns one percent or more of any class of the company's securities. The mechanism is that these relationships create incentive conflicts, and disclosure — not elimination — is the usual cure. SA checklist: market making, banking fees, other pay, firm ownership, all four.

Memory hook:Market maker, banker within a year, other pay, one percent owner — four flags, all disclosed.

Regulation AC requires each research analyst named in a research report to certify, within the report itself, two things: that the views expressed accurately reflect the analyst's personal views about the subject securities, and that no part of the analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed. The certification must appear in research reports, and the firm must obtain and preserve the signed statements. The mechanism is personal accountability: the analyst, not just the firm, stands behind the conclusions. SA decision rule: every covered report with a named analyst carries the certification — no exceptions, no delegation.

Memory hook:Two signed promises: these are my views, and no pay rides on this pick.

Rule 2241 requires every research report to explain the firm's rating system and to place the subject company within it. The report must define what each rating — buy, hold, sell, or the firm's equivalents — actually means, including the meaning of any related price target and the time horizon over which the rating applies. Separately, the report must include a ratings distribution chart or table showing the percentage of the firm's ratings in each category and, within each category, how many subject companies are or were investment banking clients. The mechanism: a buy label is meaningless without definitions, and the distribution exposes whether the firm grades harshly or hands out buys.

Memory hook:Define the rating, then show the whole pie — banking clients included.

Rule 2241 requires research reports to disclose whether analyst compensation is based on overall firm revenues, including investment banking revenue. The harder edge is the prohibition: a firm may not promise, expressly or impliedly, that an analyst will receive compensation tied to a specific investment banking transaction. The distinction is the whole lesson. Compensation linked to general firm performance is permitted if disclosed; compensation contingent on a particular deal closing, or on the analyst's recommendation about a banking client, is flatly prohibited, and disclosure cannot cure it. SA review: read the compensation disclosure language and confirm no analyst's bonus is wired to any single transaction.

Memory hook:Firm-wide pay, disclosed: allowed. One-deal pay: banned, disclosure or not.

Rule 2241 requires a research report that includes a price target to disclose the basis for it — the valuation method and the methodology used to determine the number. That means identifying the approach, whether discounted cash flow, earnings multiples, comparable companies, or sum-of-the-parts, along with the key assumptions driving it and the risks that could impede achieving the target. A bare number with no derivation fails, and so does a target that contradicts the rating. SA decision rule: the target must be traceable — a reader should connect the methodology and assumptions to the number, and the number to the recommendation. No naked numbers.

Memory hook:Method, assumptions, risks — and the target must match the rating.

When a research analyst makes a public appearance — media, seminars, webinars, sales presentations, non-deal road shows — Rule 2241 requires specific disclosures if the analyst offers an opinion or recommendation. The set mirrors report disclosures: whether the firm or analyst received compensation from the subject company in the past twelve months, whether the firm makes a market in the security, whether the analyst or a household member owns the security, and whether analyst compensation is tied to firm revenues including investment banking. The firm must have policies ensuring these disclosures are made and documented. Mechanism: the live audience gets the same conflict information a report reader would.

Memory hook:Same conflicts, same stage: the podium gets the report's disclosures.

When research content presents non-GAAP measures — adjusted EPS, EBITDA, free cash flow — Regulation G principles govern the presentation. The most directly comparable GAAP measure must appear with equal or greater prominence than the non-GAAP figure, a clear reconciliation must bridge the two, and the non-GAAP measure must be labeled and its difference from GAAP explained. A report headlining adjusted EPS of two dollars while burying GAAP EPS in a footnote fails prominence; a non-GAAP figure with no reconciliation fails outright. SA review rule: every non-GAAP number needs a GAAP companion, a bridge, and a label. The recurring trap is selective emphasis on the flattering figure.

Memory hook:Every non-GAAP number walks in with its GAAP twin and a reconciliation bridge.

Rule 2241 requires firms to establish, maintain, and enforce written procedures governing research analyst personal trading. Analysts must give notice and obtain preclearance before trading securities of companies they cover, and the firm must keep records of analyst holdings and transactions sufficient to supervise the activity. The mechanism is preventive: preclearance lets compliance block a trade that would breach a blackout or contrary-trading restriction before it happens, while the records prove supervision after the fact. For the Supervisory Analyst acting as liaison, the job is making sure the approval pipeline and the trading-preclearance pipeline both operate and both leave a paper trail.

Memory hook:Ask first, trade second, and keep the paper trail current.

The analyst trading restrictions in Rule 2241 reach beyond the account in the analyst's own name. They extend to accounts in which the analyst holds beneficial ownership — household accounts, accounts of immediate family members living in the household, and accounts the analyst controls or funds. The mechanism is economic interest, not account title: a spouse's brokerage account or a family trust the analyst established is treated as the analyst's own for preclearance and blackout purposes, because the analyst benefits from the trades either way. SA decision rule: when an analyst's trade request comes in, sweep the related accounts too, not just the personal one.

Memory hook:Beneficial ownership follows the money: spouse, household, or trust all count.

Rule 2241 bars a research analyst from trading contrary to the analyst's most recently published recommendation within thirty days after publication of a research report on the subject company. Counting starts at publication, so an analyst maintaining a buy rating cannot sell the stock during the window. Narrow exceptions exist, including trades caused by broad market movements and unsolicited customer-directed transactions. The mechanism prevents an analyst from telling clients to buy while personally selling into the recommendation's momentum. SA task: confirm the recommendation's direction, the publication date, and whether an exception genuinely applies before any trade clears.

Memory hook:Thirty days after publication, the analyst trades with the recommendation or not at all.

Rule 2241 prohibits a research analyst from serving as an officer or director of a subject company the analyst covers, and it bars a member from allowing an officer or director of a covered company to publish research on that company. The mechanism is structural: an analyst who sits inside management has access to inside information and a divided loyalty that no disclosure or recusal can fix. Where an analyst serves as an officer or director of a covered company more generally, the firm must disclose it and apply safeguards. SA decision rule: check outside positions before assigning coverage — if a directorship exists, the analyst does not cover the company.

Memory hook:Cover the company or sit on its board — never both.

Rule 2241 flatly prohibits a firm from promising, expressly or impliedly, that a research analyst will receive compensation based on a specific investment banking transaction. An analyst covering a company cannot have a bonus contingent on that company's deal closing. Contrast the permitted arrangement: compensation tied to overall firm revenues, including investment banking revenue, is allowed if disclosed in the report. The mechanism is the conflict itself — deal-specific pay gives the analyst a direct stake in flattering the banking client, which is precisely what research rules exist to prevent. SA review: scrutinize compensation plans and report disclosure language for any transaction-linked promises.

Memory hook:Firm revenue, disclosed: fine. One deal, one bonus: banned.

Public appearances — media interviews, seminars, webinars, sales presentations — are communications with the public under Rule 2210, but they are exempt from the rule's filing and pre-approval requirements. The exemption stops at procedure: everything said must still be fair, balanced, not misleading, grounded in a reasonable basis, and free of exaggerated or promissory language. Firms must maintain written procedures for supervising public appearances, including documenting what was said. The mechanism: an analyst's off-the-cuff claim that a stock cannot lose violates Rule 2210 on television exactly as it would in print. SA role: train and monitor, because pre-approval is not the safety net here.

Memory hook:No filing needed, but spoken words still follow the written rules.

A public appearance under FINRA Rule 2241 is any interactive forum—seminar, webinar, sales presentation, or non-deal roadshow—where the analyst's statements reach clients, prospects, or the public. The analyst must make the same conflict disclosures required in a written report, may not offer a view that differs materially from the current report without publishing an updated one, and the firm must make a good faith effort to capture the content. The sharpest trap: an analyst may not participate in a non-deal roadshow when the firm is soliciting investment banking business from the subject company, because that appearance looks like a quid pro quo for future banking fees. Supervision means reviewing scripts, slides, and Q&A conduct.

Memory hook:No banking solicitation, no roadshow seat; public talk mirrors the report.

Firm policies layer on top of Rule 2241's floor. Analysts may not trade contrary to their own current recommendation, and firms typically require preclearance of personal trades, impose blackout periods around report publication, and restrict trades in subject companies the analyst covers. Supervisors verify pretrade approvals, monitor related accounts such as a spouse's or dependent's, and confirm trading records are complete and retained. The exam logic is simple: a trade that contradicts the analyst's published view is a conflict, not just a paperwork lapse. When a fact pattern shows an analyst buying ahead of an upgrade or selling before a downgrade, the conduct violates both firm policy and the rule itself.

Memory hook:An analyst never trades against the ink that carries their name.

The subject company can check facts, not opinions. Rule 2241 permits the company to review a draft only to verify factual accuracy, and even then it must not see the rating, price target, or recommendation before publication. The analyst may ask management to confirm revenue figures or unit counts, but may not negotiate language, soften risk disclosures, or let the company preview conclusions. Any comments the company offers must be documented and reviewed by legal or compliance. If the conversation drifts into material nonpublic information—earnings guidance, deal chatter—the analyst must stop and escalate. The exam tests the line: factual verification is allowed; influence, preview of opinions, and MNPI are not.

Memory hook:The subject company checks the math but never sees the verdict.

Investment banking and research must stay separated because banking fees create an incentive to slant coverage. Rule 2241 bars investment banking personnel from supervising analysts or evaluating their compensation, and it restricts routine communication between the two groups. When contact is genuinely necessary—for example, to resolve a factual issue involving an offering—the conversation must be chaperoned: legal or compliance sits in, documents the exchange, and ensures no promises of favorable coverage or threats of downgrade are made. The exam loves fact patterns where a banker 'just wants a quick word' with the analyst about an upcoming report. Unchaperoned, undocumented contact is the violation even if the substance turns out harmless.

Memory hook:Banker and analyst talk only with a chaperone in the room.

Before a report goes to clients, almost nobody outside research gets a preview. Rule 2241 prohibits providing a draft or its substance to sales and trading personnel ahead of publication, because a preview lets favored accounts or the firm's own book trade on the coming recommendation. The exceptions are narrow: legal and compliance may see drafts for supervisory review, and the subject company may verify facts without seeing opinions. Supervisors enforce this with access controls—locked drafts, restricted distribution lists, and audit trails showing who opened what and when. If a salesperson asks an analyst which way the rating is going before publication, the correct answer is no answer, and the contact itself should be reported.

Memory hook:Sales and trading read the report when clients do.

Once a report is published, every client entitled to receive it must get it at effectively the same time. Rule 2241 requires simultaneous or nearly simultaneous distribution to all firm customers, and a firm may not hand the report first to a favored institutional account, a large prospect, or an internal desk. Selective distribution is the core abuse: someone trades on the recommendation before the broader market sees it. The exam pattern is a timeline: if one account gets the report at 9:00 and the rest at noon, the firm has a dissemination problem regardless of intent. The SA's control is distribution-list discipline and timestamped release records.

Memory hook:Everyone entitled reads at once; no favorites get the report early.

Regulation FD binds issuers, not broker-dealers. When a senior company official selectively discloses material nonpublic information to a securities professional, the issuer must make public disclosure—simultaneously if the disclosure was intentional, promptly if it was not. For the research side, the practical consequence is timing: if an analyst receives MNPI in a management meeting, the firm cannot publish related research until the information is public. The analyst should also escalate immediately, because trading or writing on the information before disclosure creates insider trading exposure. The exam hinge is who is liable: the issuer bears the Reg FD obligation, while the firm that received the information bears the misuse consequences. Distinguish the issuer's duty from the firm's duty.

Memory hook:Reg FD disciplines the issuer's mouth, not the analyst's pen.

When an analyst suspects information received is material nonpublic, the first move is escalation, not judgment. The analyst should stop the conversation, document what was heard and from whom, and promptly report to legal and compliance. Compliance then decides the response: place the issuer on the restricted or watch list, delay or cancel the pending report, wall off the analyst, and assess whether the source must make public disclosure under Regulation FD. The exam pattern is an analyst who quietly works around the information or waits to see if it becomes public—that compounds insider trading risk with a supervision failure. Escalation is both the analyst's duty and the firm's safe path, and the record of that escalation matters.

Memory hook:Hear a secret? Stop, log it, hand it to compliance.

Draft control is how firms prove the right people saw the right version. Pre-publication, drafts should circulate only within research and to legal or compliance for required review; sales, trading, investment banking, and the subject company are out, except the narrow factual-verification exception for the company. Version control matters: each draft should be numbered or timestamped, approvals recorded, and the final approved version preserved alongside the published one. When a fact pattern shows a draft emailed to a salesperson, a banker, or the subject company's CFO with the rating visible, multiple violations stack up—preview, selective access, and possibly MNPI. The supervisor's job is designing systems that make leakage visible, not just telling people to be careful.

Memory hook:Numbered drafts, locked doors: only research and compliance hold the pen.

Third-party research is a report prepared by an outside broker-dealer or affiliate that the firm distributes to its clients. The distributing firm does not adopt the third party's conclusions, but the material is not unregulated: the report must carry the third party's required disclosures, the firm must maintain supervisory procedures governing what it distributes, and it must not alter the substance without permission. Information barriers still apply, so a firm whose bankers work with the subject company cannot use a third party's report to do indirectly what its own analysts could not do directly. The exam tests whether distribution is passive or promotional—promoting the report makes it the firm's own communication.

Memory hook:Distributing a stranger's report still runs on your supervision.

The Supervisory Analyst registration is a defined category under FINRA Rule 1220, and Rule 1210 governs how it is obtained. The path: the member firm files a Form U4 requesting the SA position in CRD, the candidate passes both parts—Series 161 (regulations) and Series 162 (valuation)—and FINRA records the approval. Two mechanics the exam stresses: a candidate who passed CFA Level I is exempt from Part II, and the registration is effective on the date SA approval posts to CRD, not the date the exam was passed. The sponsoring firm drives the paperwork; an individual cannot self-register. If one part is failed, only that part is retaken.

Memory hook:Firm files U4, both parts pass, CRD date controls.

Continuing education has two pieces. The Regulatory Element is prescribed training FINRA assigns to registered persons, tied to their registration categories, and must be completed on schedule or the registration can be suspended by FINRA. The Firm Element is the firm's own needs-based training plan, driven by an analysis of its business, products, and customers. NYSE Rule 345A imposes parallel obligations on NYSE members. For a Supervisory Analyst, the practical point is that CE lapses are not private matters: a lapsed SA cannot act as one, and the firm's supervisory system must track completion. The exam frames this as consequences—an overdue Regulatory Element leads to inactive status, not a fine.

Memory hook:Regulatory Element from FINRA, Firm Element from your own needs analysis.

NYSE Rule 342(b)(1) requires each office of a member organization to be supervised by one or more delegated supervisory persons, with the firm's supervisory system providing review of customer accounts, supervision of registered persons, and review of the entity's business. Delegation is allowed, but ultimate responsibility stays with the firm and its designated principals—a supervisor cannot outsource accountability. For the research context, this rule supplies the structural answer when a question asks who is responsible for an analyst's conduct at a branch or department: the delegated supervisor in that unit, backed by the firm's written supervisory procedures. The exam pairs this rule with failures like unsupervised communications, and the answer is the supervisory system, not the individual alone.

Memory hook:You can delegate the task, never the accountability.

Rule 17a-4 tells firms what to keep and how. Research reports, the approvals that cleared them, and related communications are books and records that must be preserved under defined retention schedules—commonly three years with the first two easily accessible, and longer for certain corporate records. Electronic storage is permitted but conditioned on the medium: non-rewriteable, non-erasable storage, or an audit-trail equivalent that prevents undetected alteration, plus an index and the ability to promptly produce records to regulators. For the SA, the exam point is proof: when a question asks how a firm demonstrates that a report was properly reviewed, the answer is the retained approval record, timestamped and retrievable. Records nobody can produce are records the firm effectively never kept.

Memory hook:If it was approved, it must be kept—unchangeably.

Rules 2010 and 2020 are the conscience clauses. Rule 2010 requires observance of just and equitable principles of trade and standards of commercial honor; Rule 2020 prohibits manipulative, deceptive, or otherwise fraudulent devices. Neither lists specific conduct, and that is exactly why they matter: they catch what the detailed rules do not name. A research communication that is technically compliant with Rule 2210's content standards can still violate 2010 if it is misleading in context—cherry-picked performance, a rating the analyst does not believe, or pressure on an analyst to flatter a banking client. The SA's judgment is anchored here. When an exam fact pattern feels wrong but no specific rule is cited, the answer is usually a 2010 or 2020 violation.

Memory hook:When no rule names the sin, 2010 and 2020 do.

Section 5(b)(1) of the Securities Act makes it unlawful to deliver a security unless accompanied by a prospectus meeting the Act's requirements, and any communication that qualifies as a prospectus must comply. During a registered offering, ordinary research or marketing material can accidentally become an illegal prospectus. The safe harbors carve out what does not count: Rule 134 permits limited tombstone-style announcements with prescribed factual content; Rule 135 permits a notice of a proposed registered offering, again within content limits; Rule 135a permits generic advertising that does not reference a specific offering. The exam move is classification: given a communication during an offering, ask whether it fits a safe harbor, references a specific security, or crosses into offering material demanding prospectus treatment.

Memory hook:Tombstone, notice, or generic ad—otherwise it may be a prospectus.

Section 12 of the Securities Act creates civil liability tied to prospectuses and related communications. Under 12(a)(1), selling a security without a registration statement or without delivering the required prospectus exposes the seller to buyer rescission. Under 12(a)(2), any person who offers or sells a security by means of a prospectus or oral communication containing a material misstatement or omission is liable to the purchaser, who may recover the purchase price. The defense worth knowing: a person who did not know, and in the exercise of reasonable care could not have known, of the untruth escapes 12(a)(2) liability—so diligence and documented review are the protection. For the SA, sloppy numbers in offering-related research are not just a FINRA problem; they are a lawsuit.

Memory hook:Bad numbers in the prospectus buy the buyer a refund.

Rule 144 is the safe harbor for reselling restricted or controlled securities outside registration: it sets conditions like holding periods, manner-of-sale limits, and current public information requirements, and its mechanics matter to analysts because coverage of a thinly traded stock can shade into helping a distribution. Rule 144A permits private resales of securities to qualified institutional buyers, creating a market in unregistered securities where research is often the only price discovery available. The exam angle: an analyst whose report effectively touts a stock while an affiliate or holder is dumping shares raises Section 5 gun-jumping and manipulation concerns. Restricted does not mean uncoverable, but the SA must confirm the report is independent analysis, not distribution support.

Memory hook:Rule 144 frees the holder; 144A sells to the big institutions.

Exchange Act Section 9 attacks manipulation of exchange-listed securities: wash sales, matched orders, and false or misleading statements made to affect a price. Rule 10b-5 is broader, reaching fraud in connection with the purchase or sale of any security—misstatements, omissions, and schemes to defraud. Research sits at the intersection because a published report moves prices. An analyst who publishes a rating without a reasonable basis, trades ahead of the report, or slants coverage to help a banking client has crossed from weak analysis into potential fraud. The SA's review is the control: verify the basis for opinions, watch for exaggeration, and check trading around publication. Manipulation requires intent to affect price; 10b-5 requires deception in connection with a trade.

Memory hook:Section 9 rigs the price; 10b-5 lies about the trade.

Exchange Act Section 15D is where the SEC's authority over securities analysts lives. Section 15D(d) directs the SEC to adopt rules regarding securities analysts and research reports designed to foster greater public confidence in securities markets and protect investors—authority the SEC used to build the analyst conflict regime, including Regulation AC. Regulation AC requires analysts to certify in each report that the views expressed are accurately reflected and that their compensation was not tied to the specific recommendation, with a trigger for re-certification if the firm knowingly fails to include the statement. The exam tests the certification's content: personal belief plus no recommendation-linked pay. When a question asks the source of the SEC's analyst rules, the answer is Section 15D.

Memory hook:15D(d) powers the SEC; Regulation AC certifies the analyst's honest pen.